ALLIANCEBERNSTEIN L.P. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2021$196,000
+28.1%
56,900
-6.1%
0.00%
Q4 2020$153,000
+19.5%
60,6000.0%0.00%
Q3 2020$128,000
-30.1%
60,600
-26.0%
0.00%
Q2 2020$183,000
+20.4%
81,900
+36.7%
0.00%
Q1 2020$152,000
+63.4%
59,900
+69.2%
0.00%
Q4 2019$93,000
-26.8%
35,4000.0%0.00%
Q3 2019$127,000
+6.7%
35,4000.0%0.00%
Q2 2019$119,000
+35.2%
35,400
+9.6%
0.00%
Q1 2019$88,000
-2.2%
32,3000.0%0.00%
Q4 2018$90,000
-32.3%
32,3000.0%0.00%
Q3 2018$133,000
-20.8%
32,3000.0%0.00%
Q2 2018$168,000
-2.3%
32,300
+3.2%
0.00%
Q1 2018$172,000
-77.1%
31,300
-66.0%
0.00%
-100.0%
Q4 2017$751,000
-37.7%
92,110
-20.0%
0.00%0.0%
Q3 2017$1,206,000
-5.1%
115,1500.0%0.00%0.0%
Q2 2017$1,271,000
+14022.2%
115,150
+3614.5%
0.00%
Q1 2015$9,000
-35.7%
3,1000.0%0.00%
Q4 2014$14,000
-12.5%
3,1000.0%0.00%
Q3 2014$16,000
-51.5%
3,100
-50.0%
0.00%
Q2 2014$33,0006,2000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders